Cargando…
Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects
Over the past two decades, scientific and technological advancements have revealed messenger ribonucleic acid (mRNA)-based vaccines as a well-tolerated and effective platform to combat infectious disease. The potential of mRNA-based vaccines was epitomized during the severe acute respiratory syndrom...
Autores principales: | Edwards, Darin K, Carfi, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612403/ https://www.ncbi.nlm.nih.gov/pubmed/35671599 http://dx.doi.org/10.1016/j.coi.2022.102214 |
Ejemplares similares
-
Effectiveness of Messenger Ribonucleic Acid Vaccine in Lung Transplant Recipients
por: Vender, R.J., et al.
Publicado: (2022) -
Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
por: Schauer, Jenna, et al.
Publicado: (2021) -
Messenger ribonucleic acid vaccine-associated immune thrombocytopenia: A rare complication of vaccine
por: Islamoglu, Mehmet Sami, et al.
Publicado: (2022) -
Fulminant Myocarditis 24 Days after Coronavirus Disease Messenger Ribonucleic Acid Vaccination
por: Kawano, Hiroaki, et al.
Publicado: (2022) -
Inherited Retinal Disease Therapies Targeting Precursor Messenger Ribonucleic Acid
por: Huang, Di, et al.
Publicado: (2017)